Could a vaccine stop Alzheimer's before it starts?
NCT ID NCT07158905
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 20 times
Summary
This early-stage study tests a new vaccine called AV-1980R in 48 older adults (ages 65-80) who have early signs of Alzheimer's but no memory problems. The vaccine aims to train the immune system to target a harmful protein in the brain. The main goal is to check if the vaccine is safe and well-tolerated, while also looking at whether it can slow disease-related changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Comprehensive Center for Brain Health
Boca Raton, Florida, 33433, United States
Contact
Conditions
Explore the condition pages connected to this study.